| Features: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lion’s Mane mushroom (Hericium erinaceus; “HE”; culinary + medicinal mushroom). Key bioactives include erinacines (notably erinacine A; typically mycelium-derived) and hericenones (often fruiting-body-associated), plus polysaccharides (β-glucans). Primary mechanisms (conceptual rank): Bioavailability / PK relevance: activity depends strongly on extract type (mycelium vs fruiting body; erinacine-standardized vs not). Some erinacines are reported to be BBB-permeable in the literature; human PK is not well-characterized for most commercial products. In-vitro vs oral exposure: many anti-cancer / signaling findings use extract concentrations likely above achievable systemic levels from typical supplements (qualifier: high concentration only unless otherwise demonstrated in vivo). Clinical evidence status: small human trials/pilot RCTs for cognition/early AD/MCI and healthy adults (signals but limited); cancer evidence remains largely preclinical/adjunct-hypothesis. Lion’s Mane Mushroom (Hericium erinaceus) is renowned for its potential health benefits, particularly in areas like neuroprotection, cognitive function, and immune support.-Most commonly cited mechanisms of Lion’s Mane is its ability to stimulate the synthesis of Nerve Growth Factor (NGF) -Specific compounds such as hericenones and erinacines present in the mushroom are thought to be responsible for this effect. -May inhibit NF-κB Pathway -May lower the production of pro-inflammatory cytokines (e.g., TNF-α, IL-6) -Neutralize free radicals, reducing oxidative stress -Lion’s Mane influences gut health and, in turn, the gut-brain axis -Anti-inflammatory responses, antioxidant protection -Mushrooms, including Lion’s Mane (Hericium erinaceus), contain ergosterol—a precursor to vitamin D. When exposed to ultraviolet (UV) light (such as sunlight), ergosterol is converted to vitamin D₂ (ergocalciferol). Lion’s Mane (Hericium erinaceus) — Cancer vs Normal Cell Pathway Map
TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr AD relevance: Lion’s Mane (Hericium erinaceus; especially erinacine-A–enriched mycelium preparations) is primarily studied as a neurotrophic + neuroprotective dietary intervention with small human trials/pilot RCTs in early AD/MCI and related cognitive outcomes. Primary mechanisms (conceptual rank): Bioavailability / PK relevance: effects depend on standardized preparations (erinacine A content; dosing regimen). Evidence base includes a ~49-week pilot double-blind placebo-controlled study of erinacine-A–enriched mycelium; overall evidence remains limited by sample sizes and product variability. Clinical evidence status: small human trials/pilot RCTs (signals but not definitive; adjunct/early evidence). Lion’s Mane (Hericium erinaceus) — AD/Neurodegeneration Pathway Map
TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr |
| Source: |
| Type: |
| In all eukaryotic cells, intracellular Ca2+ levels are maintained at low resting concentrations (approximately 100 nM) by the activity of the major Ca2+ extrusion system, the plasma membrane Ca2+-ATPase (PMCA), which exchanges extracellular protons (H+) for cytosolic Ca2+. Indeed, sustained elevation of [Ca2+]C in the form of overload, saturating all Ca2+-dependent effectors, prolonged decrease in [Ca2+]ER, causing ER stress response, and high [Ca2+]M, inducing mitochondrial permeability transition (MPT), are considered to be pro-death factors. In cancer the Ca2+-handling toolkit undergoes profound remodelling (figure 1) to favour activation of Ca2+-dependent transcription factors, such as the nuclear factor of activated T cells (NFAT), c-Myc, c-Jun, c-Fos that promote hypertrophic growth via induction of the expression of the G1 and G1/S phase transition cyclins (D and E) and associated cyclin-dependent kinases (CDK4 and CDK2). Thus, cancer cells may evade apoptosis through decreasing calcium influx into the cytoplasm. This can be achieved by either downregulation of the expression of plasma membrane Ca2+-permeable ion channels or by reducing the effectiveness of the signalling pathways that activate these channels. Such protective measures would largely diminish the possibility of Ca2+ overload in response to pro-apoptotic stimuli, thereby impairing the effectiveness of mitochondrial and cytoplasmic apoptotic pathways. Voltage-Gated Calcium Channels (VGCCs): Overexpression of VGCCs has been associated with increased tumor growth and metastasis in various cancers, including breast and prostate cancer. Store-Operated Calcium Entry (SOCE): SOCE mechanisms, such as STIM1 and ORAI1, are often upregulated in cancer cells, contributing to enhanced cell survival and proliferation. High intracellular calcium levels are associated with increased cell proliferation and migration, leading to a poorer prognosis. Calcium signaling can also influence hormone receptor status, affecting treatment responses. Increased Ca²⁺ signaling is associated with advanced disease and metastasis. Patients with higher CaSR expression may have a worse prognosis due to enhanced tumor growth and resistance to apoptosis. -Ca2+ is an important regulator of the electric charge distribution of bio-membranes. |
| - | in-vitro, | AD, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:325 Target#:38 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid